We next assessed the level of cell surface CDCP1 in 49 cell lines from a diverse range of adenocarcinomas, including seven from kidney, nine from lung, four from colorectal, 20 from ovarian and two from prostate cancer and seven from PDAC. This evidence concerns the gene CDCP1 and Familial prostate cancer.